1 completed, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow Arteriosclerosis Obliterans: new trials by email Literature Review of Arteriosclerosis Obliterans trials Research Report on Arteriosclerosis Obliterans
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sufficient Treatment of Peripheral Intervention by Cilostazol cilostazol - Arteriosclerosis Obliterans | Phase 4 | Unknown | Kansai Rosai Hospital | 200 | 2009-03-01 | 2010-07-22 |
| Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker Cilostazol, Probucol, Cilostazol+Probucol - Type 2 Diabetes Mellitus, Arteriosclerosis Obliterans | Phase 4 | Completed | Otsuka Beijing Research Institute | 200 | 2008-10-01 | 2025-03-27 |
Arterial Occlusive Diseases (2) · Arteriosclerosis (2) · Cardiovascular Diseases (2) · Vascular Diseases (2) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
Cilostazol (2) · Control Groups (1) · Probucol (1)
Kansai Rosai Hospital (1) · Otsuka Beijing Research Institute (1)
China (1) · Japan (1)
Osamu Iida (1) · Xiaohui Guo, M.D. (1)